☆ 4.7 Letter

2017 ECIL 7 vaccine guidelines

LANCET INFECTIOUS DISEASES (2019)

Journal

LANCET INFECTIOUS DISEASES

Volume 19, Issue 7, Pages 694-695

Publisher

ELSEVIER SCI LTD

DOI: 10.1016/S1473-3099(19)30277-4

Keywords

-

Categories

Infectious Diseases

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada

Danuta M. Skowronski, Siobhan Leir, Suzana Sabaiduc, Catharine Chambers, Macy Zou, Caren Rose, Romy Olsha, James A. Dickinson, Anne-Luise Winter, Agatha Jassem, Jonathan B. Gubbay, Steven J. Drews, Hugues Charest, Tracy Chan, Rebecca Hickman, Nathalie Bastien, Yan Li, Mel Krajden, Gaston De Serres

Summary: This study investigates the genetic diversity of influenza A(H3N2) viruses and the impact of vaccination history on vaccine effectiveness. The findings show heterogeneity in vaccine effectiveness and suggest that pivotal mutations and repeat vaccination using unchanged antigen may reduce vaccine effectiveness.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Emily T. Martin, Caroline Cheng, Joshua G. Petrie, Elif Alyanak, Manjusha Gaglani, Donald B. Middleton, Shekhar Ghamande, Fernanda P. Silveira, Kempapura Murthy, Richard K. Zimmerman, Arnold S. Monto, Christopher Trabue, H. Keipp Talbot, Jill M. Ferdinands

Summary: The study evaluated the vaccine effectiveness against A(H3N2) during the 2016-2017 and 2017-2018 influenza seasons, finding relatively low effectiveness against the A(H3N2) vaccine virus, especially A/Hong Kong/4801/2014. This suggests ongoing changes in H3N2 antigenic epitopes may impact the vaccine efficacy.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017

Ann Versporten, Robin Bruyndonckx, Niels Adriaenssens, Niel Hens, Dominique L. Monnet, Geert Molenberghs, Herman Goossens, Klaus Weist, Samuel Coenen

Summary: This article reviews data on cephalosporin consumption in the community from 30 EU/EEA countries over two decades, showing a significant shift towards consumption of more broad-spectrum cephalosporins during 1997-2017. Despite considerable variation between countries in the composition of cephalosporin consumption and trends over time, a noticeable increase in proportional consumption of second- and third-generation cephalosporins, and decrease in fourth-generation cephalosporin consumption, was observed.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Add to Collection

Article Immunology

Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination

Antonia Morga, Tomomi Kimura, Qi Feng, Nigel Rozario, Jason Schwartz

Summary: This study evaluated compliance to pneumococcal vaccination recommendations for adults aged >= 65 years and with high-risk conditions. The findings showed low compliance rates and suggested the need for additional efforts to improve vaccination rates to reduce the incidence and burden of pneumococcal disease.

VACCINE (2022)

Add to Collection

Article Immunology

Waning Vaccine Protection against Influenza among Department of Defense Adult Beneficiaries in the United States, 2016-2017 through 2019-2020 Influenza Seasons

Wenping Hu, Paul A. Sjoberg, Anthony C. Fries, Laurie S. DeMarcus, Anthony S. Robbins

Summary: The objective of this study was to assess the effectiveness of inactivated influenza vaccine in adults aged >= 18 years using a test-negative design and considering the time since vaccination. The study analyzed data from the US Department of Defense Global Respiratory Pathogen Surveillance Program over four influenza seasons and found that the vaccine effectiveness decreased over time after vaccination.

VACCINES (2022)

Add to Collection

Article Multidisciplinary Sciences

Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017

Alhassan Mohammed Yakubu, Nii Ayite Aryee, Evelyn Yayra Bonney, Erasmus Nikoi Kotey, Joseph Humphrey Kofi Bonney, Michael R. Wiley, Catherine B. Pratt, Grace Korkor Ababio, Shieley Nimo-Paintsil, Naiki Puplampu, Seth Attoh, Raymond D. Fatchu, Edward Owusu Nyarko, Anne Fox, Chaselynn M. Watters, Terrel Sanders, Andrew G. Letizia, William Kwabena Ampofo

Summary: Recent reports of mismatch between vaccine composition strains and circulating strains have raised concerns about influenza B viruses. In this study, the lineages of influenza B viruses circulating in Ghana between 2016 and 2017 were characterized. Several amino acid substitutions were identified in both B/Victoria and B/Yamagata lineages. Monitoring the evolution of influenza B viruses is crucial for the selection of representative viruses and the formulation of effective vaccines.

PLOS ONE (2022)

Add to Collection

Review Public, Environmental & Occupational Health

A retrospective review of vaccine wastage and associated risk factors in the Littoral region of Cameroon during 2016-2017

Rene Nkenyi, Gi Deok Pak, Calvin Tonga, Yun Chon, Se Eun Park, Sunjoo Kang

Summary: Vaccine wastage is a significant issue in Cameroon's immunization program, with factors such as vaccination site characteristics, seasonality, and types of vaccines contributing to the wastage. Further research is needed to understand the socio-behavioral aspects affecting vaccination and wastage levels across Cameroon.

BMC PUBLIC HEALTH (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of DTaP Against Pertussis in?2-Year-Old Children-Linyi Prefecture, Shandong Province, China, 2017-2019

Pinpin Zhu, Dan Wu, Yan Wang, Xiaoxue Liu, Lance E. Rodewald, Yixing Li, Hui Zheng, Lei Cao, Yifan Song, Li Song, Xiaodong Zhao, Jianyi Yao, Fuzhen Wang, Mingshuang Li, Qian Zhang, Tingting Yan, Zundong Yin

Summary: This study shows that the effectiveness of co-purified DTaP vaccine against pertussis-related illnesses increases with the number of doses administered. Previous research indicated VE rates of 42% for one dose, 88% for two doses, and 95% for three doses. However, this new study found that VE rates range from 24%-26% after one dose to 86%-87% after four doses.

CHINA CDC WEEKLY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia

Zihan Ma, Chenfeng Mao, Xiao Chen, Shiyu Yang, Zhihua Qiu, Baoqi Yu, Yiting Jia, Chao Wu, Yiyi Wang, Yuhui Wang, Rui Gu, Fang Yu, Yanhui Yin, Xian Wang, Qingbo Xu, Chuanju Liu, Yuhua Liao, Jingang Zheng, Yi Fu, Wei Kong

Summary: This study designed three potential vaccines to inhibit atherosclerosis. Among them, ATS7vac vaccine was found to effectively inhibit intimal thickening and restenosis in mice and pigs. The vaccine suppressed ADAMTS-7-mediated protein degradation, reduced smooth muscle cell migration, and promoted re-endothelialization.

CIRCULATION (2023)

Add to Collection

Article Immunology

AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period

Yunda Huang, Kelly E. Seaton, Martin Casapia, Laura Polakowski, Stephen C. De Rosa, Kristen Cohen, Chenchen Yu, Marnie Elizaga, Carmen Paez, Maurine D. Miner, Colleen F. Kelley, Janine Maenza, Michael Keefer, Javier R. Lama, Magdalena Sobieszczyk, Susan Buchbinder, Lindsey R. Badenj, Carter Lee, Vineeta Gulati, Faruk Sinangil, David Montefiori, M. Juliana McElrath, Georgia D. Tomaras, Harriet L. Robinsonm, Paul Goepfert

Summary: The HVTN 114 study investigated the impact of late boosting with AIDSVAX B/E on the durability and breadth of vaccine-induced immune responses in participants previously enrolled in HVTN 205. The results showed that late boosting with AIDSVAX, alone or in combination with MVA, led to increased binding antibody responses and T-cell responses even years after the initial vaccination.

VACCINE (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Evaluation of adverse events following immunization reported during national immunization programs (Between 2017-2019 in Ankara Province)

A. Cigdem Simsek, Elif Arabulan, Nilufer Tavukcu, Sertac cankaya, Belgin Gulhan, Aslinur Ozkaya-Parlakay

Summary: Between 2017 and 2019, Ankara administered approximately 1.7 million doses of vaccines with only 71 reported adverse events following immunization (AEFI), demonstrating a low risk associated with vaccination.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Add to Collection

Review Immunology

The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines

Juan Huang, Zhiyao Long, Renyong Jia, Mingshu Wang, Dekang Zhu, Mafeng Liu, Shun Chen, Xinxin Zhao, Qiao Yang, Ying Wu, Shaqiu Zhang, Bin Tian, Sai Mao, Xumin Ou, Di Sun, Qun Gao, Anchun Cheng

Summary: IL-7 is a crucial cytokine produced by various cells in the body, playing a key role in regulating lymphocyte development, survival, and immune responses against pathogens. Its functions include orchestrating gene rearrangement in precursor B and T cells, activating immune cells, and improving vaccine efficacy by enhancing immune responses.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing

Juan Li, Zhujiazi Zhang, Herun Zhang, Maozhong Li, Xiaomei Li, Li Lu, Fang Huang, Jiang Wu

Summary: This study investigated the seroprevalence of poliovirus antibodies in Beijing before and after the polio vaccine switch in 2012 and 2017, finding lower P1 and P3 antibody levels in 2017 compared to 2012. Differences in neutralizing antibodies for all poliovirus serotypes were observed among different age and vaccination groups in both 2012 and 2017. Monitoring of poliovirus antibody seroprevalence after the adjustment of the polio vaccine immunization schedule in 2020 is essential.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Add to Collection

Article Nutrition & Dietetics

Dietary Intake and Pneumococcal Vaccine Response Among Children (5-7 Years) in Msambweni Division, Kwale County, Kenya

Eleonora Migliore, Vivian K. Amaitsa, Francis M. Mutuku, Indu J. Malhotra, Dunstan Mukoko, Anika Sharma, Prathik Kalva, Amrik S. Kang, Charles H. King, A. Desiree LaBeaud

Summary: This study conducted in Kenya reveals the prevalence of chronic malnutrition and highlights the links between adequate nutrient intake, socioeconomic conditions, and vaccine efficacy.

FRONTIERS IN NUTRITION (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators

Anne Huppertsberg, Leonard Kaps, Zifu Zhong, Sascha Schmitt, Judith Stickdorn, Kim Deswarte, Francis Combes, Christian Czysch, Jana De Vrieze, Sabah Kasmi, Niklas Choteschovsky, Adrian Klefenz, Carolina Medina-Montano, Pia Winterwerber, Chaojian Chen, Matthias Bros, Stefan Lienenklaus, Niek N. Sanders, Kaloian Koynov, Detlef Schuppan, Bart N. Lambrecht, Sunil A. David, Bruno G. De Geest, Lutz Nuhn

Summary: pH-responsive nanogels were fabricated for safe delivery of TLR7/8-stimulating imidazoquinolines, showing a spatially controlled immunostimulatory activity in the spleen after intravenous injection, without causing systemic off-target inflammatory responses. This approach highlights the potential of pH-degradable nanogels as a promising platform for intravenous administration of small-molecular TLR7/8 agonists in immune therapeutic applications.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Add to Collection

Article Biophysics

Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey

Moshe Yeshurun, Uri Rozovski, Liat Shargian, Oren Pasvolsky, Steffie van der Werf, Gloria Tridello, Nina Knelange, Malgorzata Mikulska, Jan Styczynski, Diana Averbuch, Rafael de la Camara

Summary: We conducted a study to describe the infection prevention practices among EBMT centers. Questionnaires were sent to all 553 centers and responses from 127 centers in 32 countries were obtained. The study revealed significant variations in antimicrobial prophylaxis practices, medications employed and duration of preventive therapy among the centers.

BONE MARROW TRANSPLANTATION (2023)

Add to Collection

Article Oncology

Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009

Thomas Lehrnbecher, Andreas H. Groll, Simone Cesaro, Julia Alten, Andishe Attarbaschi, Draga Barbaric, Nicole Bodmer, Valentino Conter, Shai Izraeli, Georg Mann, Anja Moricke, Felix Niggli, Martin Schrappe, Jan Stary, Ester Zapotocka, Martin Zimmermann, Sarah Elitzur

Summary: This study identified older children with acute lymphoblastic leukemia and those with insufficient treatment response at high risk for invasive fungal disease. It also found that invasive fungal disease is an independent risk factor for event-free and overall survival, suggesting that targeted antifungal prophylaxis may benefit these patients.

LEUKEMIA (2023)

Add to Collection

Article Hematology

Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders

Malgorzata Mikulska, Diletta Testi, Chiara Russo, Elisa Balletto, Chiara Sepulcri, Linda Bussini, Chiara Dentone, Federica Magne, Silvia Policarpo, Caterina Campoli, Filippo Miselli, Alessandro Cilli, Chiara Ghiggi, Sara Aquino, Carmen Di Grazia, Maddalena Giannella, Daniele Roberto Giacobbe, Antonio Vena, Anna Maria Raiola, Francesca Bonifazi, Pierluigi Zinzani, Michele Cavo, Roberto Lemoli, Emanuele Angelucci, Pierluigi Viale, Matteo Bassetti, Michele Bartoletti

Summary: The outcome of early treatment with antivirals or monoclonal antibodies for COVID-19 in patients with haematological malignancies is uncertain. A retrospective study was conducted to assess the efficacy of these treatments in mild/moderate cases between March 2021 and July 2022. Among the 328 patients included, treatment failure occurred in 9.5% of cases and was associated with older age, fewer vaccine doses, and monoclonal antibody therapy. The mortality rate in patients who developed severe COVID-19 despite early treatment was 26%.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Article Immunology

Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients

Malgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, Federica Magne, Elisa Balletto, Federico Baldi, Laura Labate, Chiara Russo, Michele Mirabella, Laura Magnasco, Carmen Di Grazia, Chiara Ghiggi, Anna Maria Raiola, Daniele Roberto Giacobbe, Antonio Vena, Sabrina Beltramini, Bianca Bruzzone, Roberto M. Lemoli, Emanuele Angelucci, Matteo Bassetti

Summary: This study evaluated the efficacy and safety of combination therapy in immunocompromised patients with prolonged/relapsed COVID-19. The results showed that the use of two antiviral drugs (remdesivir and nirmatrelvir/ritonavir) and anti-spike monoclonal antibodies had a high response rate in patients with prolonged/relapsed COVID-19.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Per Ljungman, Gloria Tridello, Jose Luis Pinana, Fabio Ciceri, Henrik Sengeloev, Alexander Kulagin, Stephan Mielke, Zeynep Arzu Yegin, Matthew Collin, Sigrun Einardottir, Sophie Ducastelle Lepretre, Johan Maertens, Antonio Campos, Elisabetta Metafuni, Herbert Pichler, Frantisek Folber, Carlos Solano, Emma Nicholson, Meltem Kurt Yueksel, Kristina Carlson, Beatriz Aguado, Caroline Besley, Jenny Byrne, Immaculada Heras, Fiona Dignan, Nicolaus Kroeger, Christine Robin, Anjum Khan, Stig Lenhoff, Anna Grassi, Veronika Dobsinska, Nuno Miranda, Maria-Jose Jimenez, Ipek Yonal-Hindilerden, Keith Wilson, Dina Averbuch, Simone Cesaro, Alienor Xhaard, Nina Knelange, Jan Styczynski, Malgorzata Mikulska, Rafael de la Camara

Summary: This study reports on the incidence and mortality of COVID-19 in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. It found that patients who contracted COVID-19 within 30 days or 30-100 days after transplant and those who were older and had worse immune status were at higher risk. Despite improved outcomes, there are still risks associated with severe COVID-19 in this population.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia

Daniele Roberto Giacobbe, Sara Mora, Alessio Signori, Chiara Russo, Giorgia Brucci, Cristina Campi, Sabrina Guastavino, Cristina Marelli, Alessandro Limongelli, Antonio Vena, Malgorzata Mikulska, Anna Marchese, Antonio Di Biagio, Mauro Giacomini, Matteo Bassetti

Summary: There is a study validating the accuracy of an automated system that extracts features from candidemia and/or bacteremia episodes from a hospital laboratory software, as part of the AUTO-CAND project. The manual validation process showed a correct extraction rate of over 99% for all variables, based on a random subset of 381 episodes. This dataset will be used to assess the performance of different machine learning models for the early diagnosis of candidemia in the second phase of the project.

DIAGNOSTICS (2023)

Add to Collection

Letter Oncology

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Simone Cesaro, Malgorzata Mikulska, Hans H. Hirsch, Jan Styczynski, Sylvain Meylan, Catherine Cordonnier, Davide Navarro, Marie von Lilienfeld-Toal, Varun Mehra, Francesco Marchesi, Caroline Besson, Raul Cordoba Masculano, Gernot Beutel, Herman Einsele, Johan Maertens, Rafael de la Camara, Per Ljungman, Livio Pagano

LEUKEMIA (2023)

Add to Collection

Article Infectious Diseases

Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis

Frederic Lamoth, Marcio Nucci, Ana Fernandez-Cruz, Elie Azoulay, Fanny Lanternier, Jens Bremerich, Hermann Einsele, Elizabeth Johnson, Thomas Lehrnbecher, Toine Mercier, Luciana Porto, Paul E. Verweij, Lewis White, Johan Maertens, Alexandre Alanio

Summary: (1→3)-β-D-glucan (BDG) can be used as an adjunctive tool for diagnosing invasive mold infections (IMI) in immunosuppressed patients, with a sensitivity of around 80%. Its positivity often precedes conventional diagnostic methods in detecting IF and IS. Combining BDG and galactomannan testing may improve differentiation between different types of IMI.

MEDICAL MYCOLOGY (2023)

Add to Collection

Article Anesthesiology

Italian pediatric intensive care units admitting critically ill cancer children: results from a national survey

Matteo Martinato, Rosanna I. Comoretto, Paolo Biban, Elisa Zanonato, Alessandro Simonini, Alessia Montaguti, Eloisa Gitto, Fabio Caramelli, Stefania Ferrario, Raffaella Sagredini, Nicola Alaimo, Geremia Zito Marinosci, Emanuele Rossetti, Corrado Cecchetti, Manuela L'erario, Beatrice Vasile, Giorgio Ivani, Ezio Bonanomi, Marinella Astuto, Dario Gregori, Maria C. Mondardini, Angela Amigoni

Summary: This study investigated the characteristics of Italian onco-hematological units (OHUs) and pediatric intensive care units (PICUs) that admit pediatric patients with cancer. The study found non-homogeneous availability of high-level treatments and protocols addressing end-of-life care in many centers.

MINERVA ANESTESIOLOGICA (2023)

Add to Collection

Article Medicine, General & Internal

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Tadashi Matsushita, Amy Shapiro, Aby Abraham, Pantep Angchaisuksiri, Giancarlo Castaman, Katarina Cepo, Roseline d'Oiron, Melissa Frei-Jones, Ai-Sim Goh, Jesper Haaning, Sanja Hald Jacobsen, Johnny Mahlangu, Mary Mathias, Keiji Nogami, Josephine Skovgaard Rasmussen, Oleksandra Stasyshyn, Huyen Tran, Kateryna Vilchevska, Laura Villarreal Martinez, Jerzy Windyga, Chur Woo You, Nadezhda Zozulya, Bulent Zulfikar, Victor Jimenez-Yuste

Summary: Concizumab prophylaxis reduces the annualized bleeding rate in patients with hemophilia A or B with inhibitors, and the plasma concentrations of Concizumab remain stable over time.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Review Immunology

Adenovirus infection in allogeneic hematopoietic cell transplantation

Simone Cesaro

Summary: Adenovirus (AdV) infection is common after allogeneic hematopoietic cell transplantation, especially in pediatric patients. Early diagnosis and prevention of viral replication is crucial. Cidofovir is currently the only recommended antiviral drug, but it has limited efficacy and nephrotoxicity. Enhancing virus-specific T-cell immunity may be a promising intervention.

TRANSPLANT INFECTIOUS DISEASE (2023)

Add to Collection

Review Hematology

Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review

Ibrahim N. Muhsen, Sebastian Galeano, Dietger Niederwieser, Mickey B. C. Koh, Per Ljungman, Clarisse M. Machado, Mohamed A. Kharfan-Dabaja, Rafael de la Camara, Yoshihisa Kodera, Jeff Szer, Walid Rasheed, Simone Cesaro, Shahrukh K. Hashmi, Adriana Seber, Yoshiko Atsuta, Mostafa F. Mohammed Saleh, Alok Srivastava, Jan Styczynski, Abdulrahman Alrajhi, Reem Almaghrabi, Muhammad Bilal Abid, Roy F. Chemaly, Usama Gergis, Eolia Brissot, Riad El Fakih, Marcie Riches, Malgorzata Mikulska, Nina Worel, Daniel Weisdorf, Hildegard Greinix, Catherine Cordonnier, Mahmoud Aljurf

Summary: This study aims to provide guidance to transplantation centers worldwide regarding prevention, diagnosis, and treatment of endemic and regionally limited fungal and parasitic infections in recipients of haematopoietic stem-cell transplantation. The recommendations were created and reviewed by physicians with expertise in HSCT or infectious disease. The study reviews the literature on several neglected tropical diseases including visceral leishmaniasis, Chagas disease, strongyloidiasis, malaria, schistosomiasis, histoplasmosis, blastomycosis, and coccidioidomycosis.

LANCET HAEMATOLOGY (2023)

Add to Collection

Review Hematology

Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review

Ibrahim N. Muhsen, Sebastian Galeano, Dietger Niederwieser, Mickey B. C. Koh, Per Ljungman, Clarisse M. Machado, Mohamed A. Kharfan-Dabaja, Rafael de la Camara, Yoshihisa Kodera, Jeff Szer, Walid Rasheed, Simone Cesaro, Shahrukh K. Hashmi, Adriana Seber, Yoshiko Atsuta, Mostafa F. Mohammed Saleh, Alok Srivastava, Jan Styczynski, Abdulrahman Alrajhi, Reem Almaghrabi, Muhammad Bilal Abid, Roy F. Chemaly, Usama Gergis, Eolia Brissot, Riad El Fakih, Marcie Riches, Malgorzata Mikulska, Nina Worel, Daniel Weisdorf, Hildegard Greinix, Catherine Cordonnier, Mahmoud Aljurf

Summary: This article is part one of two papers published by the Worldwide Network for Blood and Marrow Transplantation (WBMT), aiming to provide guidance on infection prevention and treatment, and considerations for transplantation. The paper summarizes data and provides recommendations on several endemic and regionally limited viral and bacterial infections.

LANCET HAEMATOLOGY (2023)

Add to Collection

Article Immunology

SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP

Daniele Zama, Andrea Zanaroli, Agnese Corbelli, Andrea Lo Vecchio, Margherita Del Bene, Antonella Colombini, Francesca Compagno, Angelica Barone, Ilaria Fontanili, Maria Rosaria D'Amico, Maria Rosaria Papa, Maria Grazia Petris, Elisabetta Calore, Shana Montalto, Linda Meneghello, Letizia Brescia, Rosamaria Mura, Milena La Spina, Paola Muggeo, Simona Rinieri, Cristina Meazza, Katia Perruccio, Monica Cellini, Manuela Spadea, Federico Mercolini, Valeria Petroni, Raffaella De Santis, Elena Soncini, Massimo Provenzi, Nagua Giurici, Ottavio Ziino, Gloria Tridello, Simone Cesaro

Summary: This study assessed the clinical impact and outcome of SARS-CoV-2 infection on children with cancer or those who received hematopoietic stem cell transplantation. The results showed that SARS-CoV-2 infection had a mild course in the Italian pediatric oncohematology population during the pandemic, and its main consequence was the discontinuation of cancer-directed therapies.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.